Myriad Genetics Inc. (MYGN)
Myriad Genetics Max Pain By Strike
MYGN trades at $5.71, 14.2% above the near-term max pain of $5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($1-$6), signaling increased put positioning or downside protection. Key magnetic zone at 5 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Myriad Genetics Max Pain By Expiry
Max pain for MYGN shows a downward trend from 6 to 1, indicating bearish sentiment or hedging activity. The 115% spread signals divergent expectations across timeframes. Most levels below 5.71 may cap rallies. Strong magnetic level at 5 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 5 | -0.71 (-12.51%) |
| Sep 19, 2025 | 6 | 0.29 (4.99%) |
| Oct 17, 2025 | 1 | -4.71 (-82.50%) |
| Nov 21, 2025 | 4 | -1.71 (-30.01%) |
| Jan 16, 2026 | 5 | -0.71 (-12.51%) |
| Feb 20, 2026 | 5 | -0.71 (-12.51%) |